Roberto Bolli, M.D., D.Sc. (Hon) FAHA, FACC

Robert Bolli, M.D.

Roberto Bolli, M.D., D.Sc. (Hon) FAHA, FACC

  • Professor of Medicine, Physiology and Biophysics
  • Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology
  • Director, Institute of Molecular Cardiology
  • Distinguished University Scholar
UofL Physicians Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-1837- Academic Office
- Patient Appointments

Clinical Expertise
General Cardiology; Cardiovascular Disease

Board Certification

  • American Board of Internal Medicine -
    Internal Medicine / Cardiovascular Disease

Education and Training

  • Medical School: University of Perugia
  • Residency: Baylor College of Medicine Affiliated Hospitals
  • Fellowship: National Institutes of Health; Baylor College of Medicine

Get To Know Dr. Bolli

Featured Publications

  • Salama ABM, Abouleisa RRE, Ou Q, Tang XL, Alhariry N, Hassan S, Gebreil A, Dastagir M, Abdulwali F, Bolli R, Mohamed TMA. Transient gene therapy using cell cycle factors reverses renin-angiotensin-aldosterone system activation in heart failure rat model. Mol Cell Biochem. 2023 Jun;478(6):1245-1250. doi: 10.1007/s11010-022-04590-2. Epub 2022 Oct 25. PMID: 36282351; PMCID: PMC10126184.
  • Nong Y, Guo Y, Ou Q, Gumpert A, Tomlin A, Zhu X, Bolli R. PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction. Mol Cell Biochem. 2023 Apr;478(4):927-937. doi: 10.1007/s11010-022-04561-7. Epub 2022 Sep 17. PMID: 36114991; PMCID: PMC10091869.
  • Bolli R, Solankhi M, Tang XL, Kahlon A. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res. 2022 Mar 16;118(4):951-976. doi: 10.1093/cvr/cvab135. PMID: 33871588; PMCID: PMC8930075.
  • Bolli R, Tang XL. New insights into cardioprotection, gained by adopting the CAESAR standards of rigor. Basic Res Cardiol. 2022 Nov 11;117(1):57. doi: 10.1007/s00395-022-00964-1. PMID: 36367590.
  • Miller JM, Meki MH, Elnakib A, Ou Q, Abouleisa RRE, Tang XL, Salama ABM, Gebreil A, Lin C, Abdeltawab H, Khalifa F, Hill BG, Abi-Gerges N, Bolli R, El-Baz AS, Giridharan GA, Mohamed TMA. Biomimetic cardiac tissue culture model (CTCM) to emulate cardiac physiology and pathophysiology ex vivo. Commun Biol. 2022 Sep 9;5(1):934. doi: 10.1038/s42003-022-03919-3. PMID: 36085302; PMCID: PMC9463130.
  • Taylor DA, Chacon-Alberty L, Sampaio LC, Hierro MGD, Perin EC, Mesquita FCP, Henry TD, Traverse JH, Pepine CJ, Hare JM, Murphy MP, Yang PC, March KL, Vojvodic RW, Ebert RF, Bolli R; Cardiovascular Cell Therapy Research Network (CCTRN). Recommendations for nomenclature and definition of cell products intended for human cardiovascular use. Cardiovasc Res. 2022 Aug 24;118(11):2428-2436. doi: 10.1093/cvr/cvab270. PMID: 34387303; PMCID: PMC9400434.
  • Tang XL, Wysoczynski M, Gumpert AM, Li Y, Wu WJ, Li H, Stowers H, Bolli R. Effect of intravenous cell therapy in rats with old myocardial infarction. Mol Cell Biochem. 2022 Feb;477(2):431-444. doi: 10.1007/s11010-021-04283-2. Epub 2021 Nov 16. PMID: 34783963; PMCID: PMC8896398.
  • Li Q, Dasari C, Li D, Arshia A, Umer AM, Abouzid MRA, Guo Y, Bolli R. Effects of Heme Oxygenase-1 on c-Kit-Positive Cardiac Cells. Int J Mol Sci. 2021 Dec 15;22(24):13448. doi: 10.3390/ijms222413448. PMID: 34948245; PMCID: PMC8704354.
  • Bolli R, Tang XL. Clinical trials of cell therapy for heart failure: recent results warrant continued research. Curr Opin Cardiol. 2022 May 1;37(3):193-200. doi: 10.1097/HCO.0000000000000956. PMID: 35612934; PMCID: PMC9178910.
  • Ostovaneh MR, Ward C, Ambale-Venkatesh B, Chamera E, Kato Y, Bolli R, Mitrani R, Perin EC, Henry TD, Hare JM, Moyé L, Nazarian S, Lima JAC. Reproducibility of CMR in Patients With Cardiac Implantable Electrical Devices: Multicenter CONCERT-HF Trial. JACC Cardiovasc Imaging. 2022 May;15(5):952-954. doi: 10.1016/j.jcmg.2021.11.023. Epub 2022 Jan 12. PMID: 35033497.